Emerging hedge fund managers touted their best ideas at the Sohn San Francisco investment conference on Tuesday.
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments
Shares of Cytokinetics, which targets medicines for specialty heart diseases, have jumped about 69% over the past three months and are up 31% year to date.
This San Francisco-based satellite company’s stock has doubled in the past three months
The stock has soared more than 215% this year despite slides earlier this year.
Top picks from the Sohn conference include digital mortgage and advertising stocks
Gaurav Gupta, founder and CIO of Floating Capital, has his eyes on Blend Labs, a digital mortgage software company.
Wells Fargo tells investors to get very long utility stocks on AI power demand, says this is not a fad
Wells Fargo analysts named Constellation Energy and Sempra among the utility stocks their clients should hold for a long time.
This derivative of the AI chip boom is poised for a breakout, according to the charts
Todd Gordon breaks down the charts and fundamentals on Dutch-based ASML.
Ray Dalio says a risky AI market bubble is forming, but may not pop until the Fed tightens
Dalio talked with CNBC’s Sara Eisen in an exclusive interview from the Future Investment Institute in Riyadh, Saudi Arabia.
This retail stock is poised for an upward mean reversion. How to trade it using options
Nishant Pant goes through this bull call spread trade on this retail name.
Here are Tuesday’s biggest analyst calls: Apple, Qualcomm, Amazon, Palantir, Reddit, Microsoft & more
Here are Tuesday’s biggest calls on Wall Street.
Why the gold pullback may be a buying opportunity for investors
Frank Holland breaks down what traders are watching ahead of the new session.